8
19 th FEB 2016

Trend today report money classic research

Embed Size (px)

Citation preview

19th

FEB 2016

Husains

MARKET WRAP

The Sensex was up 267.35 points or 1.1 percent at 23649.22 and the Nifty was up

83.30 points or 1.2 percent at 7191.75. About 1419 shares have advanced, 1118

shares declined, and 147 shares are unchanged.

Dr Reddy Labs, ONGC, Hindalco, Hero MotoCorp, ICICI Bank were top gainers while

Maruti, BHEL, Axis Bank, Reliance and Adani Ports were losers in the Sensex.

BROAD MARKET INDICES

INDEX P. CLOSE OPEN HIGH LOW CLOSE %CHANGE

NIFTY 50 7,108.45 7,177.40 7,215.15 7,127.85 7,191.75 1.17%

NIFTY NEXT 50 17,227.60 17,398.05 17,480.10 17,156.50 17,323.95 0.56%

NIFTY100 LIQ15 2,651.95 2,687.60 2,704.20 2,635.85 2,651.85 0.88%

NIFTY MIDCAP 50 2,781.90 2,812.00 2,837.95 2,752.20 2,797.65 0.57%

Contact No. +91-903-977-7700 www.moneyclassicresearch.com

ASIAN INDEXES

INDEX OPEN HIGH LOW CLOSE %CHANGE

NIKKEI 225 16,138.08 16,337.59 16,118.80 16,196.80 2.28%

HANG SENG 19,409.21 19,436.39 19,266.22 19,363.08 2.32%

TAIWAN 8,261.74 8,337.97 8,261.74 8,314.67 1.22%

SSE 2,881.78 2,893.21 2,857.70 2,862.84 -0.16%

INDIAN MAJOR SECTORAL INDICES

INDEX P. CLOSE OPEN HIGH LOW CURRENT %CHANGE

NIFTY BANK 14,119.85 14,301.75 14,385.65 14,180.90 14,298.15 1.26%

NIFTY FIN SERVICE 5,906.85 5,977.75 5,993.75 5,910.70 5,950.15 0.73%

NIFTY PHARMA 11,148.10 11,315.75 11,446.80 11,252.45 11,371.35 2.00 %

NIFTY IT 10,502.45 10,554.55 10,723.40 10,554.45 10,702.25 1.90%

Contact No. +91-903-977-7700 www.moneyclassicresearch.com

STOCK UPDATE

Monsanto India Falls 4% as Competition Watchdog

Orders Probe

Shares of agri-biotechnology major Monsanto India fell by 4 per cent today after fair

trade regulator CCI ordered a detailed probe against its US-parent joint venture

Mahyco Monsanto Biotech India Limited (MMBL).

Finding prima-facie violation of competition law, CCI has ordered a detailed probe

into alleged abuse of dominance by the Indian arm of the US-based genetically

modified seed giant Monsanto. The stock fell by 3.99 per cent to Rs 1,900.20 -- its 52

-week low -- on BSE. On NSE, it slipped 3.37 per cent to hit one-year low of Rs 1,910.

Contact No. +91-903-977-7700 www.moneyclassicresearch.com

STOCK UPDATE

Cipla advances 2% on acquisition of two US

companies

Shares of Cipla gained 2 percent intraday Thursday on acquisition of two US

companies. The company's UK arm, Cipla (EU) has completed the acquisition of two

US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc.

The acquisition was made by Cipla (EU) through a wholly owned special purpose

vehicle which would merge into InvaGen Pharmaceuticals Inc. after the acquisition.

The combined revenue for the two companies for the year-ended 2015 is over USD

230 million.

Umang Vohra, Global Chief Operating Officer, Cipla said, "The acquisition will further

stre gthe Cipla’s prese e i the US phar a euti al arket. I vaGe ’s ala ed portfolio, robust manufacturing base and strong R&D capabilities will act as lever to

expand Cipla’s rea h i the US arket."

Contact No. +91-903-977-7700 www.moneyclassicresearch.com

RECOMMENDED

ZEEL:-

BUY ZEEL AROUND 374-375 TGT 378/381/384 SL 368.

At support of 200 days moving averages and trndlines. Uptrend in daily trend. Rsi also show

buying signal and macd also in crosses zero level for buy signal.

Contact No. +91-903-977-7700 www.moneyclassicresearch.com

RECOMMENDED

WIPRO:-

BUY WIPRO AROUND 530-532 TGT 537/542/547 SL 520.

At support of 200 days moving averages and trndlines. Uptrend in daily trend. Rsi also show

buying signal and macd also in crosses zero level for buy signal.

Contact No. +91-903-977-7700 www.moneyclassicresearch.com